News | Cancer

Opinion

Clearing the COVID-19 patient treatment backlog through advancing efficient and safe delivery of care

Views from fellow pharmacists and nurses about cancer care and treatment.…

Published: 26 October 2021

Promotional content

News

Break in cancer treatment cuts side effects and does not affect life expectancy, study finds

A trial has shown that breaks from first-line treatments for patients with metastatic and/or locally advanced kidney cancer did not cause meaningful detriment to their life expectancy or quality of life.…

Published: 22 September 2021

News

NHS patients will be first in Europe to receive mutation-targeting lung cancer treatment

The tumour-agnostic drug sotorasib has been approved for the treatment of patients in England with non-small cell lung cancer.…

Published: 10 September 2021

Opinion

Chemotherapy is harming the environment: it is time for regulators, manufacturers and pharmacy to take action

Healthcare inevitably contributes to the global carbon footprint, but a more focused effort is needed to minimise the environmental impact of cancer chemotherapy.…

Published: 14 June 2021

News

CAR-T therapy extends remission in relapsed multiple myeloma patients

Median progression-free survival for patients treated with a new type of chimeric antigen receptor T-cell therapy was 8.8 months overall, increasing to 12.1 months for those treated with the maximum dose.…

Published: 13 May 2021

News

Statins may protect heart from breast cancer chemotherapy

Researchers concluded that statins may be a potential intervention for preventing heart failure in patients receiving chemotherapy.…

Published: 4 March 2021

News

New drug cuts the risk of death in bladder cancer by 30% compared with chemotherapy, study suggests

A trial comparing new antibody-drug conjugate enfortumab vedotin with chemotherapy in patients with bladder cancer has found that overall survival was longer in the group receiving the new drug.…

Published: 18 February 2021

Feature

‘Beyond our wildest dreams’ – CAR-T therapies in multiple myeloma

CAR-T therapies have been licensed in the UK since 2018 for the treatment of B cell lymphoma. But with positive results emerging for their use in multiple myeloma, and the promise of potential in solid tumours, excitement around CAR-T continues to grow.…

Published: 28 January 2021

Letter

Pharmacists have a role in the early detection of head and neck cancer

The views expressed in this letter are those of the author’s. If you would like to submit a letter to The Pharmaceutical Journal, please click here. Head and neck cancer, including cancers of the oral cavity and larynx, is the eighth most common cancer in the UK. These cancers are ch…

Published: 11 January 2021

Opinion

News | Cancer

Clearing the COVID-19 patient treatment backlog through advancing efficient and safe delivery of care

Break in cancer treatment cuts side effects and does not affect life expectancy, study finds

NHS patients will be first in Europe to receive mutation-targeting lung cancer treatment

Chemotherapy is harming the environment: it is time for regulators, manufacturers and pharmacy to take action

CAR-T therapy extends remission in relapsed multiple myeloma patients

Statins may protect heart from breast cancer chemotherapy

New drug cuts the risk of death in bladder cancer by 30% compared with chemotherapy, study suggests

‘Beyond our wildest dreams’ – CAR-T therapies in multiple myeloma

Pharmacists have a role in the early detection of head and neck cancer

Top five research articles of 2020

Download our app